25 unchanged sentences
On March 18, 2024, the parties filed a joint status report in which PGI requested the Court set a revised scheduling order and we requested grant of our motion to transfer and proposed an alternate scheduling order.
+Added: A case management conference was held on October 10, 2024 and the Court set a trial date of October 5, 2026.
We plan to vigorously defend against the remaining claims.
On December 14, 2022, Take2 Technologies, Ltd.
−Removed: ("Take2") and the Chinese University of Hong Kong filed a complaint in the U.S.
+Added: ("Take2") and the Chinese University of Hong Kong (“CUHK”) filed a complaint in the U.S.
District Court for Delaware against us alleging infringement of U.S.
12 unchanged sentences
We filed a petition for inter partes review at the Board (IPR2024-00028) challenging the validity of all claims of the ’794 patent on October 17, 2023.
−Removed: The Chinese University of Hong Kong filed a preliminary response to the petition on January 26, 2024.
+Added: The CUHK filed a preliminary response to the petition on January 26, 2024.
On April 22, 2024, we filed our answer to the complaint, denying infringement and seeking declaratory judgments of non-infringement and invalidity of the ‘794 Patent.
On April 24, 2024, the Board granted institution of IPR2024-00028 on the validity of all claims of the ’794 patent.
+Added: The CUHK filed a response to the petition and institution decision on July 26, 2024.
+Added: PacBio’s reply to CUHK’s response is due October 28, 2024.
On May 2, 2024, the parties filed a joint stipulation and proposed order to stay the Take2 District Court matter pending inter partes review.
20 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.